Publication | Closed Access

An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients

UrologyMedicineClinical TrialsGynecologyPharmacotherapyGynaecomastia InducedCancer TreatmentProstatic DiseaseOncologyEndocrine-related CancerPhase 3Tamoxifen Schedules